RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.
| Image |  |
|---|---|
| Description | scientific article published on 7 August 2017 |
| Author/s |
author: Evaristo Maiello Riziero Esposito Abate Claudia Cardone Nicola Normanno |
| Publication date | January 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |